Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schwartz Biomedical is a regenerative medicine company focused on developing innovative solutions for orthopedic and musculoskeletal conditions. The company specializes in advanced bio-polymer scaffolds and hydrogel technologies designed to facilitate the repair and regeneration of articular cartilage, bone, and soft tissues. Their product portfolio includes the Bio-Wick and Bio-Sleeve technologies, which enhance the fixation and healing of tendon-to-bone interfaces. By leveraging proprietary material science, Schwartz Biomedical aims to provide surgeons with effective alternatives to traditional tissue grafting and metal implants. The company's research and development efforts are centered on improving patient outcomes in sports medicine and joint reconstruction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schwartz Biomedical.